Matthew Geller - Net Worth and Insider Trading

Matthew Geller Net Worth

The estimated net worth of Matthew Geller is at least $0 dollars as of 2025-07-23. Matthew Geller is the Director of BioSpecifics Technologies Corp and owns about 0 shares of BioSpecifics Technologies Corp (BSTC) stock worth over $0. Details can be seen in Matthew Geller's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Geller has not made any transactions after 2011-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Matthew Geller

To

Matthew Geller Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Geller owns 1 companies in total, including BioSpecifics Technologies Corp (BSTC) .

Click here to see the complete history of Matthew Geller’s form 4 insider trades.

Insider Ownership Summary of Matthew Geller

Ticker Company Transaction Date Type of Owner
BSTC BioSpecifics Technologies Corp 2011-06-07 director

Matthew Geller Latest Holdings Summary

Matthew Geller currently owns a total of 1 stock. Matthew Geller owns 0 shares of BioSpecifics Technologies Corp (BSTC) as of June 7, 2011, with a value of $0.

Latest Holdings of Matthew Geller

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BSTC BioSpecifics Technologies Corp 2011-06-07 0 88.53 0

Holding Weightings of Matthew Geller


Matthew Geller Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew Geller has made a total of 0 transactions in BioSpecifics Technologies Corp (BSTC) over the past 5 years. The most-recent trade in BioSpecifics Technologies Corp is the sale of 10,000 shares on June 7, 2011, which brought Matthew Geller around $244,000.

Insider Trading History of Matthew Geller

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew Geller Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Geller Ownership Network

Ownership Network List of Matthew Geller

No Data

Ownership Network Relation of Matthew Geller

Insider Network Chart


Matthew Geller Owned Company Details

What does BioSpecifics Technologies Corp do?

Who are the key executives at BioSpecifics Technologies Corp?

Matthew Geller is the director of BioSpecifics Technologies Corp. Other key executives at BioSpecifics Technologies Corp include director & 10 percent owner Toby Wegman , director & Chief Executive Officer Joseph Truitt , and Chief Financial Officer Patrick Hutchison .

BioSpecifics Technologies Corp (BSTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of BioSpecifics Technologies Corp (BSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioSpecifics Technologies Corp (BSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BioSpecifics Technologies Corp (BSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioSpecifics Technologies Corp Insider Transactions

No Available Data

Matthew Geller Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Geller. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Matthew Geller's mailing address is: 248 Central Park West New York Ny 10024.